Inclisiran

From WikiMD.org
Jump to navigation Jump to search

Inclisiran (pronounced in-kli-si-ran) is a novel medication used for the treatment of hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood.

Etymology

The name "Inclisiran" is derived from the Latin words 'inclinare' meaning 'to bend' and 'serum' meaning 'blood'. This is in reference to the drug's mechanism of action, which involves altering the lipid profile in the blood.

Pharmacology

Inclisiran is a small interfering RNA (siRNA) that works by inhibiting the production of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that plays a crucial role in regulating cholesterol levels in the body. By reducing the levels of PCSK9, Inclisiran allows for greater removal of low-density lipoprotein (LDL) or "bad" cholesterol from the bloodstream.

Usage

Inclisiran is used in conjunction with a healthy diet and maximally tolerated statin therapy in adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease who require additional lowering of LDL cholesterol.

Side Effects

Common side effects of Inclisiran include fatigue, hypertension, edema, musculoskeletal pain, and diarrhea.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski